摘要
目的观察米非司酮联合甲氨蝶呤对瘢痕妊娠患者包块及血清β-HCG水平的影响。方法选取2014年7月至2016年10月收治的瘢痕子宫患者60例,随机分为对照组及观察组,各30例。所有患者均给予甲氨蝶呤,观察组加用米非司酮。观察两组患者血清β-HCG转阴时间、包块消失时间、住院时间,比较其血清β-HCG水平及疗效。结果治疗后,观察组血清β-HCG水平低于对照组,差异具有统计学意义(P<0.05);观察组各时间指标均优于对照组,差异具有统计学意义(P<0.05);观察组治疗总有效率(96.67%)高于对照组(70%),差异具有统计学意义(P<0.5)。结论对瘢痕妊娠患者给予米非司酮联合甲氨蝶呤治疗,患者血清β-HCG水平显著下降,包块消失明显,临床治疗效果显著,利于患者恢复。
Objective To observe the influence of mifepristone combined methotrexate in patients with scar pregnancy bag piece and the serum levels of beta HCG. Methods Selected our college from July 2014 to October 2016 were 60 patients with eicatricial uterus, randomly divided into two groups, control group and observation group, 30 cases each. All patients were given methotrexate, observation group with mifepristone. Observe two groups of patients with serum be- ta HCG turn time, bag piece disappear time, length of hospital stay, compare the serum beta HCG levels and curative effect. Results After treatment, the serum levels of beta HCG in observation group was lower than that of the control group, serum levels of beta HCG statistically significant difference （ P 〈 0. 05 ） ; Each time index in observation group were better than those the control group, the difference statistically significant （ P 〈 0. 05 ） ; Observation group total ef- fective rate （96. 67% ） was higher than that of the control group （70%）, statistically significant difference （P 〈0. 5）. Condusion Of scar pregnancy patients given mifepristone combined methotrexate therapy, with a significant reduction in the serum of beta HCG levels, bag piece were obviously, clinical treatment effect significantly, beneficial to patients＇ recovery.
出处
《医药论坛杂志》
2017年第4期67-68,共2页
Journal of Medical Forum
